Contact Lens Spectrum

References

Special Edition

Document #SE2019

(p. 6) The Size of the Myopia Problem
By Kate Gifford, PhD, BAppSc(Optom)Hons

  1. Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042.
  2. Chen M, Wu A, Zhang L, et al. The increasing prevalence of myopia and high myopia among high school students in Fenghua city, eastern China: a 15-year population-based survey. BMC Ophthalmol. 2018;18:159.
  3. Rudnicka AR, Kapetanakis VV, Wathern AK, et al. Global variations and time trends in the prevalence of childhood myopia, a systemic review and quantitative meta-analysis: implications for aetiology and early prevention. Br J Ophthalmol. 2016 Jul;100(7):882-890.
  4. Wolffsohn JS, Calossi A, Cho P, et al. Global trends in myopia management attitudes and strategies in clinical practice. Cont Lens Anterior Eye. 2016 Apr;39(2):106-116.
  5. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012 Nov;31(6):622-660.
  6. Bullimore MA, Brennan NA. Myopia control: why each diopeter matters. Optom Vis Sci. 2019 Jun;96(6):463-465.
  7. Tideman JW, Snabel MC, Tedja MS, et al. Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia. JAMA Ophthalmol. 2016 Dec;134(12):1355-1363.
  8. Wolffsohn JS, Kollbaum PS, Berntsen DA, et al. IMI – clinical myopia control trials and instrumentation report. Invest Ophthalmol Vis Sci. 2019 Feb;60(3):M132-M160.
  9. Gifford KL, Richdale K, Kang P, et al. IMI – clinical management guidelines report. Invest Ophthalmol Vis Sci. 2019 Feb;60(3):M184-M203.
  10. Wildsoet CE, Chia A, Cho P, et al. IMI – interventions myopia institute: interventions for controlling myopia onset and progression report. Invest Ophthalmol Vis Sci. 2019 Feb;60(3):M106-M131.
  11. Jones L, Drobe B, González-Méijome JM, et al. IMI – industry guidelines and ethical considerations for myopia control report. Invest Ophthalmol Vis Sci. 2019 Feb;60(3):M161-M183.

(p. 50) The Economics of Myopia Control
By Clarke D. Newman, OD, FAAO

  1. Ruiz-Medrano J, Montero JA, Flores-Moreno I, et al. Myopic maculopathy: current status and proposal for a new classification and grading system (ATN). Prog Retin Eye Res. 2019 Mar;69:80-115.
  2. Holden BA, Fricke TR, Wilson DA, et al. Global prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology. 2016;123(5):1036-1042.
  3. National Eye Institute. Eye health data and statistics. 2019. Available at: https://nei.nih.gov/eyedata/myopia#1
  4. Walline JJ. Myopia control: a review. Eye Contact Lens. 2016 Jan;42(1):3-8.
  5. Vagge A, Ferro Desideri, L, Nucci P, et al. Prevention of progression in myopia: a systematic review. Diseases. 2018 Sep;6(4):92.

(p. 51) Going from Zero to Hero
By David L. Kading, OD

  1. Cho P, Cheung SW, Edwards M. The longitudinal orthokeratology research in children (LORIC) in Hong Kong: a pilot study on refractive changes and myopic control. Cur Eye Res. 2005;30(1):71-80.
  2. Walline JJ, Jones LA. Sinnott LT. CRAYON Study. Corneal reshaping and myopia progression Br J Ophthalmol 2009;93:1181-1185.
  3. Reim TR, Lund M, Wu R. Orthokeratology and adolescent myopia control. Contact Lens Spectrum. 2003 Mar.

(p. 52) The Benefits of Contact Lenses for Children
By Melanie Frogozo, OD

  1. Sindt CW. Pediatric contact lens fitting. In manual of contact lens prescribing and fitting (Third Edition). Butterworth-Heinemann. 2006. 599-636.
  2. Walline JJ, Sindt CW, Bennett E. Children and contact lenses. In clinical manual of contact lenses (Fourth Edition), Bennett ES, Henry VA, eds. Lippincott Williams and Wilkins, 2014.
  3. Walline JJ., Jones LA, Sinnott L, et al; ACHIEVE Study Group. Randomized trial of the effect of contact lens wear on self-perception in children. Optom Vis Sci. 2009 Mar;86:222-232.
  4. Walline JJ, Jones LA, Rah MJ, et al; CLIP Study Group. Contact Lenses in Pediatrics (CLIP) Study: chair time and ocular health. Optom Vis Sci. 2007 Sep;84:896-902.
  5. Chalmers RL, Wagner H, Mitchell GL, et al. Age and other risk factors for corneal infiltrative and inflammatory events in young soft contact lens wearers from the Content Lens Assessment in Youth (CLAY) study. Invest Ophthalmol Vis Sci. 2011 Aug;52(9):6690-6696.
  6. Lindsay RG, Chi JT. Contact lens management of infantile aphakia. Clin Exp Optom. 2010 Jan;93(1):3-14.
  7. Shaughnessy MP, Ellis FJ, Jeffery AR, Szczotka L. Rigid gas-permeable contact lenses are a safe and effective means of treating refractive abnormalities in the pediatric population. CLAO J. 2001 Oct;27(4):195-201

(p. 53) Myopia Management with Orthokeratology
By Michael J. Lipson, OD

  1. Huang J, Wen D, Wang Q, et al. Efficacy comparison of 16 interventions for myopia control in children: a network meta-analysis. Ophthalmology. 2016 Apr;123(4):697-708.
  2. Holden BA, Jong M, Davis S, et al. Nearly 1 billion myopes at risk of myopia-related sight-threatening conditions by 2050 – time to act now. Clin Exp Optom. 2015 Nov;98(6):491-493.
  3. Vitale S, Sperduto RD, Ferrid FL 3rd. Increased prevalence of myopia in the United States between 1971-1972 and 1999-2004. Arch Ophthalmol. 2009 Dec;127(12):1632-1639.
  4. Cho BJ, Shin JY, Yu HG. Complications of pathologic myopia. Eye Contact Lens. 2016 Jan;42(1):9-15.
  5. Saw SM, Gazzard G, Shih-Yen EC, Chua WH. Myopia and associated pathological complications. Ophthalmic Physiol Opt. 2005 Sep;25(5):381-391.
  6. Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012 Nov;31(6):622-660.
  7. Cho P, Cheung SW. Retardation of myopia in Orthokeratology (ROMIO) study: a 2-year randomized clinical trial. Invest Ophthalmol Vis Sci. 2012 Oct;53(11):7077-7085.
  8. Wen D, Huang J, Chen H, et al. Efficacy and acceptability of orthokeratology for slowing myopic progression in children: a systematic review and meta-analysis. J Ophthalmol. 2015;2015(3):1-12.
  9. Si JK, Tang K, Bi HS, et al. Orthokeratology for myopia control: a meta-analysis. Optom Vis Sci. 2015 Mar;92(3):252-257.
  10. Sun Y, Xu F, Zhang T, et al. Orthokeratology to control myopia progression: a meta-analysis. PLoS One. 2015 Apr;10(4):e0124535.
  11. Lipson MJ. Long-term clinical outcomes for overnight corneal reshaping in children and adults. Eye Contact Lens. 2008 Mar;34:94–99.
  12. Lipson MJ, Sugar A, Musch DC. Overnight corneal reshaping versus soft disposable contact lenses: vision-related quality-of-life differences from a randomized clinical trial. Optom Vis Sci. 2005 Oct;82(10):886-891.
  13. Hiraoka T, Okamoto C, Ishii Y, et al. Patient satisfaction and clinical outcomes after overnight orthokeratology. Optom Vis Sci. 2009 Jul;86(7):875-882.
  14. Bullimore MA, Sinnott LT, Jones-Jordan LA. The risk of microbial keratitis with overnight corneal reshaping lenses. Optom Vis Sci. 2013 Sep;90(9):937-944.
  15. Liu YM, Xie P. The safety of orthokeratology – a systemic review. Eye Contact Lens. 2016 Jan;42(1):35-42.
  16. Bullimore MA, Brennan NA. Myopia control: why each diopeter matters. Optom Vis Sci. 2019 Jun;96(6):463-465.